LJ10 LLC enters PEAR THERAPEUTICS, INC. with 12.93M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/8/2021ACC: 0000899243-21-047380
12.93M
Baseline shares
100% direct
12.93M
Direct ownership
2 positions
5.01M
Derivative underlying
1 instrument
2
Security positions
All direct
Non-Derivative Holdings2
Class A Common Stock
DirectShares owned6.54M
Class A Common Stock
DirectShares owned6.39M
Total
12.93M direct12.93M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 6.54M | Direct |
| Class A Common Stock | 6.39M | Direct |
| Total | 12.93M | 12.93M direct |
Derivative Holdings1
Private Placement Warrants
DirectUnderlying security
Class A Common Stock
Underlying shares
5.01M
Shares owned
N/A
Exercise price
11.50
Expiration
—
Exercise window
—
Total
Underlying
5.01M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Private Placement Warrants Direct | Class A Common Stock | 11.50 | — | — | 5.01M | N/A |
| Total | 5.01M | 0.00 | ||||